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ABSTRACT
Introduction: Endoscopic sclerotherapy to control variceal bleeding in adults has been proven to be
useful. Complications from this procedure that have been reported include esophageal stricture,
perforation, mediastinitis and recurrent bleeding. This procedure has increasingly been used in pediatric
patients, thus increasing the incidence of its complications.
The purpose of this study: To report the effect of sclerotherapy in variceal bleeding
Method: All patients that underwent sclerotherapy since 1989 were included in the study and were
followed up until December 1999. We recorded the frequency of injections, recurrent bleeding, and gastropathy.
Results: During the last ten years, we have used sclerotherapy in 26 patients. The varices were secondary
to intrahepatic portal hypertension. The average age at initial sclerotherapy was 7 years (ranging from 1-12
years). Two patients died following initial sclerotherapy. Nine patients could not be followed up and 17
patients were under monitoring for 2-10 years. Four patients died after 2-8 years of follow up due to the
underlying diseases. Complete obliteration of all varices was obtained in 12 cases, minimal residual varices
in four and 1 case was unfavorable for injection. Six patients (35.3%) suffered from recurrent bleeding; 4
patients had minimal residual varices (1 year follow up), and 2 patients had complete obliteration (3 years
follow up). Gastropathy was found in 6 patients after 12 to 32 sessions of injection. Complications such as
perforation or stricture were not found.
Conclusions: Sclerotherapy is a very useful technique to control variceal bleeding in children. We found
recurrent bleeding and gastropathy in 35.3% patients. Other complications were not found.
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INTRODUCTION
Endoscopic sclerotherapy is very useful to control
variceal bleeding, which make up 9% of acute upper
gastrointestinal bleeding in children. This procedure is
increasingly used in pediatric patients, thus increasing
the incidence rate of complications such as esophageal
stricture, esophageal perforation, and mediastinitis. This
method can reduce the frequency and severity of
recurrent variceal bleeding. This procedure is preferred
for patients who are not surgical candidates because the
method appears to be as good as shunt surgery.
Repeated sclerotherapy is needed to decrease the rate
of recurrent bleeding and to improve survival.  The
session can be done in an outpatient clinic at 2 to 4 weeks
intervals until all varices were obliterated. Endoscopic
follow up at 6-12 months intervals is advised to prevent
recurrent bleeding. The purpose of this study is to report
the effect of sclerotherapy in variceal bleeding and its
complications in children.
PATIENTS AND METHOD
All patients who underwent endoscopic sclerotherapy
were included in the study. The study took place from
July 1989 to December 1999. We recorded the
diagnoses of underlying diseases, the patient’s age, the
frequency of injections, recurrent bleeding, gastropathy,
or other complications. We used general anesthesia in
all patients. Injections were repeated every 1 to 2 weeks
based on the patients status and was stopped if the
varices had been obliterated. All patients were followed
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up endoscopically every 6-12 months. Injections may be
either paravariceal, intravariceal, or both. A sclerosing
agent (ethoxysclerol 1%) was injected to the distal
esophagus. Patients were followed up for 2-10 years.
RESULTS
Twenty-six patients who underwent sclerotherapy
were included in the study. The age of the patients at
initial sclerotherapy ranged from 1-12 years (mean 7
years). Almost all of our patients underwent the Kasai
procedure, except one who had portal vein thrombosis.
Two patients died following initial sclerotherapy due to
the underlying diseases. Nine patients could not be
followed up.  Seventeen patients were monitored for 2-
10 years. Four patients died after 2-8 years follow up
due to underlying diseases. Complete obliteration was
obtained in 12 cases (70,6 %), minimal residual varices
in 4 cases, and unfavorable for injections in one case
(Table 1.)
Table 1. Result of Sclerotherapy 
 Number of 
patients (%) 
Recurrent 
Bleeding 
Complete obliteration 12 (70.6) 2 
Minimal Residual 
Varices 
4 (23.5) 4 
 
almost the same as the other study in the literature. Some
of our cases could not come in a regular basis due to
financial problems. However, we were able to follow up
17 cases for 2-10 years. During the study period, 6
patients died due to underlying diseases, two of them at
initial sclerotherapy and 4 of them during follow up.  From
the patients who underwent sclerotherapy, two thirds of
them demonstrated a good response (complete
obliteration), and only few of them still had minimal
residual varices. In one case, we could not inject the
varices because of technical difficulties. We performed
12 to 32 injections of sclerotherapy. There was one
patient who received 32 injections. This might have been
due to the severity of the varices. During study period,
the incidence of recurrent bleeding was almost the same
as in another study1. Interestingly, patients from the
minimal residual varices group had a higher rate of
recurrent bleeding (twice) and the time to the point of
recurrent bleeding was shorter than in the complete
obliteration group (1 year vs. 3 years). However, it was
difficult to the know prognosis of the patient or when
they would suffer from recurrent bleeding.2, 3 In
addition, we found gastropathy among our cases. The
etiology of such condition is still unclear. Some
investigators hypothesized that it might occur due to bad
mucosal circulation of the stomach. Sclerotherapy was
proven to be useful to control variceal bleeding and
decreased mortality rate. 4, 5 During follow up, 6 patients
died due to the underlying diseases, and no one due to
variceal bleeding. This data confirmed some reports that
sclerotherapy increased mortality rate due to underlying
diseases but decreased mortality rate due to variceal
bleeding. 6, 7 At the end of the study, the oldest patient
was 19 years old and suffered from no recurrent
bleeding in the last five years. However, the mortality
rate due to hepatic failure is still high, as found in other
reports.8, 9 No complications such as esophageal
stricture or perforation were found, and only one case
had severe bleeding during sclerotherapy requiring
transfusion. This result is lower than reports in the
literature. 10, 11
CONCLUSION
Sclerotherapy is a very useful technique to control
variceal bleeding in children, and it can improve the
survival rate of our patients. We found recurrent
bleeding and gastropathy in 35.3 % patients. Other
complications were not found.
The complications were as follows: recurrent
bleeding in 6 patients (35.3%) and gastropathy in 6
patients (35.3%) (after 12-32 sessions). During 3 years
follow up, we found recurrent bleeding in 4 patients who
had minimal residual varices and in 2 patients who had
complete obliteration.
DISCUSSION
Esophageal varices in children is not uncommon.
During a 10-year period, we managed 26 cases of
esophageal varices due to portal hypertension. Almost
all patients except one had varices due to intrahepatic
portal hypertension and liver cirrhosis. Variceal bleeding
was reported as the major cause of death in these
patients, and sclerotherapy was proven to be useful to
control variceal bleeding.  In our study, the youngest age
of variceal bleeding was one year. The bleeding was not
directly related to the severity of cirrhosis or liver
function test. It might be related to the blood pressure in
the portal vein. Unfortunately, because our study was a
retrospective study, we did not measure the pressure of
the portal vein. The average age of our patients was
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